Nodexus

Berkeley, United States Founded: 2014 • Age: 12 yrs
Microfluidic systems are developed for detecting metastatic cancer.
Request Access

About Nodexus

Nodexus is a company based in Berkeley (United States) founded in 2014 by Anand Kesavaraju and Karthik Balakrishnan.. Nodexus has raised $31.2 million across 4 funding rounds from investors including HHS, RA Capital and S32. The company has 27 employees as of December 31, 2022. Nodexus offers products and services including NX One, NX One MAX, and NX One PRO. Nodexus operates in a competitive market with competitors including 10X Genomics, Mission Bio, NanoCellect Biomedical, Cellares and ThinkCyte, among others.

  • Headquarter Berkeley, United States
  • Employees 27 as on 31 Dec, 2022
  • Founders Anand Kesavaraju, Karthik Balakrishnan
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nodexus Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $31.2 M (USD)

    in 4 rounds

  • Latest Funding Round
    $30 M (USD), Series A

    Dec 16, 2021

  • Investors
    HHS

    & 7 more

  • Employee Count
    27

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Nodexus

Nodexus offers a comprehensive portfolio of products and services, including NX One, NX One MAX, and NX One PRO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Benchtop device for gentle single-cell sorting and dispensing.

System for large particle sorting in organoid and spheroid applications.

Multi-laser configuration for advanced fluorescence-based cell analysis.

People of Nodexus
Headcount 10-50
Employee Profiles 4
Board Members and Advisors 3
Employee Profiles
People
Hany Nassef
VP, Engineering
People
Karthik Balakrishnan
Founder & CEO
People
Anand Kesavaraju
Founder & Chief Strategy Officer
People
Stephanie Pappas
Sr. Sales Specialist

Unlock access to complete

Board Members and Advisors
people
Ashraf Hanna
Advisory Board Member
people
Diether Recktenwald
Advisory Board Member
people
Joseph Keegan
Advisory Board Member

Unlock access to complete

Funding Insights of Nodexus

Nodexus has successfully raised a total of $31.2M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $30.0M
  • First Round

    (01 Dec 2014)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2021 Amount Series A - Nodexus Valuation RA Capital Management
S32
Sep, 2019 Amount Grant - Nodexus Valuation

investors

HHS
Sep, 2018 Amount Grant - Nodexus Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nodexus

Nodexus has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, RA Capital and S32. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Tech startups are funded by S32, a venture capital entity.
Founded Year Domain Location
Women-led startups are funded through stage-agnostic investments and angel networks.
Founded Year Domain Location
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nodexus

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nodexus

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nodexus Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nodexus

Nodexus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, NanoCellect Biomedical, Cellares and ThinkCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Instrument systems for genomic research and sequencing libraries are developed.
domain founded_year HQ Location
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
domain founded_year HQ Location
Develops flow cytometry and cell sorting technology
domain founded_year HQ Location
Medical devices for cell-based therapy manufacturing are produced.
domain founded_year HQ Location
Cell analysis and sorting technologies are developed with AI integration.
domain founded_year HQ Location
Optical tweezers instruments for single-molecule analysis are manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nodexus

Frequently Asked Questions about Nodexus

When was Nodexus founded?

Nodexus was founded in 2014.

Where is Nodexus located?

Nodexus is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Who is the current CEO of Nodexus?

Karthik Balakrishnan is the current CEO of Nodexus. They have also founded this company.

Is Nodexus a funded company?

Nodexus is a funded company, having raised a total of $31.2M across 4 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Dec 01, 2014.

How many employees does Nodexus have?

As of Dec 31, 2022, the latest employee count at Nodexus is 27.

What does Nodexus do?

Nodexus was founded in 2014 in Berkeley, United States, within the biotechnology sector. Microfluidic systems are developed by the company for the detection of metastatic cancer. A single-use cartridge forms the core of the platform technology, enabling isolation of circulating tumor cells. Label-free methods are employed, which minimize sample preparation time. Operations focus on advancing diagnostic tools for oncology applications.

Who are the top competitors of Nodexus?

Nodexus's top competitors include 10X Genomics, Mission Bio and NanoCellect Biomedical.

What products or services does Nodexus offer?

Nodexus offers NX One, NX One MAX, and NX One PRO.

Who are Nodexus's investors?

Nodexus has 8 investors. Key investors include HHS, RA Capital, S32, Astia, and Andrew Mendelsohn.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available